BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 16004476)

  • 1. Tumor characterization with dynamic contrast enhanced magnetic resonance imaging and biodegradable macromolecular contrast agents in mice.
    Wu X; Feng Y; Jeong EK; Emerson L; Lu ZR
    Pharm Res; 2009 Sep; 26(9):2202-8. PubMed ID: 19597972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface PEG Grafting Density Determines Magnetic Relaxation Properties of Gd-Loaded Porous Nanoparticles for MR Imaging Applications.
    Zhang W; Martinelli J; Peters JA; van Hengst JMA; Bouwmeester H; Kramer E; Bonnet CS; Szeremeta F; Tóth É; Djanashvili K
    ACS Appl Mater Interfaces; 2017 Jul; 9(28):23458-23465. PubMed ID: 28657291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gadolinium Metallofullerene-Based Activatable Contrast Agent for Tumor Signal Amplification and Monitoring of Drug Release.
    Wang S; Zhou Z; Wang Z; Liu Y; Jacobson O; Shen Z; Fu X; Chen ZY; Chen X
    Small; 2019 Apr; 15(16):e1900691. PubMed ID: 30913380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.
    Zhang W; Liu L; Chen H; Hu K; Delahunty I; Gao S; Xie J
    Theranostics; 2018; 8(9):2521-2548. PubMed ID: 29721097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biodegradable iodinated polydisulfides as contrast agents for CT angiography.
    Jin E; Lu ZR
    Biomaterials; 2014 Jul; 35(22):5822-9. PubMed ID: 24768156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin-coated gadolinium nanoparticles as MRI contrast agent.
    Korkusuz H; Ulbrich K; Welzel K; Koeberle V; Watcharin W; Bahr U; Chernikov V; Knobloch T; Petersen S; Huebner F; Ackermann H; Gelperina S; Kromen W; Hammerstingl R; Haupenthal J; Gruenwald F; Fiehler J; Zeuzem S; Kreuter J; Vogl TJ; Piiper A
    Mol Imaging Biol; 2013 Apr; 15(2):148-54. PubMed ID: 22811020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An extracellular MRI polymeric contrast agent that degrades at physiological pH.
    Schopf E; Sankaranarayanan J; Chan M; Mattrey R; Almutairi A
    Mol Pharm; 2012 Jul; 9(7):1911-8. PubMed ID: 22657107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydisulfide Based Biodegradable Macromolecular Magnetic Resonance Imaging Contrast Agents.
    Lu ZR; Wu X
    Isr J Chem; 2010 Aug; 50(2):220-232. PubMed ID: 21331318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macromolecular and dendrimer-based magnetic resonance contrast agents.
    Bumb A; Brechbiel MW; Choyke P
    Acta Radiol; 2010 Sep; 51(7):751-67. PubMed ID: 20590365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macromolecules, dendrimers, and nanomaterials in magnetic resonance imaging: the interplay between size, function, and pharmacokinetics.
    Villaraza AJ; Bumb A; Brechbiel MW
    Chem Rev; 2010 May; 110(5):2921-59. PubMed ID: 20067234
    [No Abstract]   [Full Text] [Related]  

  • 11. Noninvasive monitoring of HPMA copolymer-RGDfK conjugates by magnetic resonance imaging.
    Zarabi B; Borgman MP; Zhuo J; Gullapalli R; Ghandehari H
    Pharm Res; 2009 May; 26(5):1121-9. PubMed ID: 19160028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineered polymers for advanced drug delivery.
    Kim S; Kim JH; Jeon O; Kwon IC; Park K
    Eur J Pharm Biopharm; 2009 Mar; 71(3):420-30. PubMed ID: 18977434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural effect on degradability and in vivo contrast enhancement of polydisulfide Gd(III) complexes as biodegradable macromolecular MRI contrast agents.
    Zong Y; Wang X; Jeong EK; Parker DL; Lu ZR
    Magn Reson Imaging; 2009 May; 27(4):503-11. PubMed ID: 18814987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPMA copolymer-doxorubicin-gadolinium conjugates: synthesis, characterization, and in vitro evaluation.
    Zarabi B; Nan A; Zhuo J; Gullapalli R; Ghandehari H
    Macromol Biosci; 2008 Aug; 8(8):741-8. PubMed ID: 18484565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping.
    Ke T; Jeong EK; Wang X; Feng Y; Parker DL; Lu ZR
    Int J Nanomedicine; 2007; 2(2):191-9. PubMed ID: 17722547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydisulfide Gd(III) chelates as biodegradable macromolecular magnetic resonance imaging contrast agents.
    Lu ZR; Mohs AM; Zong Y; Feng Y
    Int J Nanomedicine; 2006; 1(1):31-40. PubMed ID: 17722260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gd-DTPA L-cystine bisamide copolymers as novel biodegradable macromolecular contrast agents for MR blood pool imaging.
    Kaneshiro TL; Ke T; Jeong EK; Parker DL; Lu ZR
    Pharm Res; 2006 Jun; 23(6):1285-94. PubMed ID: 16729223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-g-poly(GdDTPA-co-L-cystine): effect of PEG chain length on in vivo contrast enhancement in MRI.
    Mohs AM; Zong Y; Guo J; Parker DL; Lu ZR
    Biomacromolecules; 2005; 6(4):2305-11. PubMed ID: 16004476
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.